Engineered M13 phage-based biosensor offers rapid, label-free detection of SARS-CoV-2 spike protein, demonstrating femtogram-level sensitivity in tests.

A Statistical Immune Correlates of Protection Model for Predicting Efficacy from Neutralizing Antibody Titers to Establish Immunobridging of ...

Nandkumar M. Kamat In December 2019, a cluster of unusual pneumonia cases surfaced in Wuhan, China. Within weeks, the world ...

COVID-19 vaccination during the 2024-2025 respiratory virus season was associated with protection against hospitalization.

COVID-19 vaccination showed effectiveness in reducing hospitalizations and severe disease outcomes associated with the SARS-CoV-2 JN.1 lineage, according to a recent study published in JAMA Network ...

By Hugo Francisco de Souza A novel nasal booster approach may help close the gap between systemic vaccination and infection-blocking mucosal immunity, offering fresh insight into next-generation COVID ...

We demonstrates an innovative strategy for mucosal vaccine design by integrating bacterial N-terminal fatty acylation into a glycosylated RBD. LipoSC synergistically enhances the immunogenicity of RBD ...

In summer 2025, the SARS-CoV-2 JN.1 sublineage became dominant with more resistant variants, such as XFG, LP.8.1, and NB.1.8.1. COVID-19 mRNA boosters were therefore updated for the 2025–2026 season ...

A group of Connecticut researchers now better understand the current coronaviral landscape of wild and domestic animals in the northeastern United ...

COVID-19 severity appears to be declining among hospitalized children as the Omicron variant continues to evolve.

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This ...